Gilead Sciences Inc (GILD)
Gilead - Gilead to Showcase Interim Long-Term Efficacy Data forLivdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta
Gilead - Gilead to Showcase Interim Long-Term Efficacy Data forLivdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta
There are no comments here yet...